ОбзорГрафикНовостиTraderScreen

L&S Knock-Out BIO/  DE000LS1NF50  /

Lang & Schwarz
14.11.2024  22:59:28 Изменение-0.06 Бид22:59:28 Предложение22:59:28 Базовый актив Цена исполнения Дата истечения Тип опциона
2.01EUR -2.90% 2.01
Величина цены спроса: -		 2.05
Величина цены предложения: -		 BB BIOTECH AG 20.8774 EUR 31.12.2078 Call
Newsfile Corp 15.08 Edison Issues Report on BB Biotech (BION)
GlobeNewswire 02.04 Abivax reports 2023 financial results and operational update
GlobeNewswire 28.03 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire 27.11.2023 Arvinas Announces Oversubscribed $350 Million Private Placement
GlobeNewswire 08.03.2022 NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
GlobeNewswire 17.06.2021 Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
TeleTrader 15.04.2021 Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report
TeleTrader 14.04.2021 EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4
TeleTrader 11.11.2020 Pfizer, BioNTech grant EU 200 million vaccine doses
GlobeNewswire 16.12.2019 Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire 19.10.2018 Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire 02.01.2018 Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire 06.12.2017 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
GlobeNewswire 19.10.2017 Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire 02.12.2016 Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire 21.10.2016 Biotech stocks continue to advance
GlobeNewswire 11.10.2016 BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 11.10.2016 Ad hoc: BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 29.07.2016 Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire 22.07.2016 BB Biotech: Stabilization of biotech sector in the second quarter of 2016
GlobeNewswire 15.07.2016 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 14.07.2016 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 11.07.2016 BB Biotech AG with after-tax loss in the first half year of 2016
GlobeNewswire 23.06.2016 BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Secu...
GlobeNewswire 22.04.2016 BB BIOTECH AG: Challenging first quarter for biotech investments